LAVA Therapeutics (LVTX)
(Delayed Data from NSDQ)
$1.68 USD
0.00 (0.00%)
Updated Sep 19, 2024 03:55 PM ET
After-Market: $1.66 -0.02 (-1.19%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth C Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 33% (84 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.37 | 9.99 |
Current Quarter Estimate | -0.35 | 3.10 | 61.00 |
Year Ago Quarter Estimate | -0.34 | -4.81 | 54.84 |
Next Quarter Estimate | -0.30 | 3.85 | 63.00 |
Next Year Estimate | -1.55 | 24.86 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 18.47 | 17.20 | 15.67 |
Next Year | -21.09 | 9.40 | 11.34 |
Last 5 Years | NA | 0.90 | 8.10 |
Next 5 Years | NA | 22.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -6.44 |
Price/Book (MRQ) | 0.50 | 2.10 |
Price/Cash Flow (MRFY) | NA | 16.43 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -228.02% | -150.51% |
Return on Equity (TTM) | -48.53% | -61.16% |
Debt to Equity (MRQ) | 0.01 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.